Active Ingredient History
Desflurane is a non-flammable liquid administered via vaporizer as a general anesthetic. It is halogenated exclusively with fluorine and is very resistant to defluorination. For this reason, it is not associated with nephrotoxicity, as is the case with other inhalational anesthetics. Desflurane is indicated for the induction and/or maintenance of anesthesia and adults, and for maintenance of anesthesia in pediatric patients following the induction with other agents. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Muscle Relaxation (approved 1992)
Adenocarcinoma (Phase 4)
Airway Extubation (Phase 4)
Airway Management (Phase 4)
Analgesics, Opioid (Phase 4)
Anesthesia (Phase 4)
Anesthesia and Analgesia (Phase 4)
Anesthesia, General (Phase 4)
Anesthetics (Phase 4)
Aortic Valve Stenosis (Phase 4)
Arthritis (Phase 4)
Arthroplasty, Replacement, Knee (Phase 2)
Bariatric Surgery (Phase 4)
Biliary Atresia (Phase 4)
Breast Neoplasms (Phase 4)
Calculi (Phase 4)
Carcinoma, Hepatocellular (Phase 4)
Cardiovascular Diseases (Phase 4)
Carotid Stenosis (Phase 4)
Cholangiocarcinoma (Phase 4)
Cognition Disorders (Phase 4)
Colorectal Neoplasms (Phase 4)
Coronary Artery Bypass (Phase 4)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Craniotomy (Phase 4)
Cystoscopes (Phase 3)
Cytomegalovirus Infections (Phase 2)
Delayed Emergence from Anesthesia (Phase 4)
Desflurane (Phase 4)
Down Syndrome (Phase 2)
Emergence Delirium (Phase 4)
End Stage Liver Disease (Phase 4)
Erythema Infectiosum (Phase 1/Phase 2)
Fatigue (Phase 4)
Funnel Chest (Phase 4)
Gallbladder Neoplasms (Phase 4)
General Surgery (Phase 3)
Healthy Volunteers (Phase 4)
Heart Arrest (Phase 4)
Hepatectomy (Phase 3)
Hepatitis C (Phase 1)
HIV Infections (Phase 2/Phase 3)
HIV Seronegativity (Phase 1)
Immunization (Phase 1)
Influenza A Virus, H1N1 Subtype (Phase 3)
Influenza A Virus, H5N1 Subtype (Phase 2)
Influenza, Human (Phase 4)
Influenza in Birds (Phase 2)
Kidney Failure, Chronic (Phase 4)
Laparoscopy (Phase 4)
Laryngeal Masks (Phase 4)
Lasers (Phase 4)
Liver (Phase 4)
Liver Transplantation (Phase 4)
Lung Neoplasms (Phase 4)
Melanoma (Phase 4)
Microcirculation (Phase 4)
Musculoskeletal Diseases (Phase 3)
Nausea (Phase 4)
Neoplasms (Phase 4)
Neoplastic Cells, Circulating (Phase 4)
Obesity (Phase 4)
Orthopedic Procedures (Phase 2)
Osteoarthritis (Phase 4)
Oxygen Saturation (Phase 4)
Pain (Phase 3)
Pain, Postoperative (Phase 2)
Pancreatic Neoplasms (Phase 4)
Pandemics (Phase 2)
Pediatrics (Phase 1/Phase 2)
Pneumonectomy (Phase 4)
Postoperative Cognitive Complications (Phase 4)
Postoperative Complications (Phase 4)
Postoperative Nausea and Vomiting (Phase 2)
Pregnancy (Phase 1)
Prostatic Neoplasms (Phase 4)
Prostheses and Implants (Phase 2)
Renal Insufficiency (Phase 4)
Reperfusion Injury (Phase 4)
Respiratory Aspiration (Phase 4)
Respiratory Syncytial Virus Infections (Phase 1)
Respiratory System Abnormalities (Phase 4)
Rotator Cuff Injuries (Phase 4)
Sevoflurane (Phase 3)
Sleep Apnea, Obstructive (Phase 4)
Sleep Apnea Syndromes (Phase 4)
Spinal Diseases (Phase 4)
Strabismus (Phase 4)
Surgical Oncology (Phase 4)
Thoracic Surgery (Phase 4)
Ureteral Diseases (Phase 4)
Urinary Bladder Diseases (Phase 4)
Vaginal Diseases (Phase 4)
Vascular Diseases (Phase 4)
Ventricular Dysfunction (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
